CNNP(SH:601985)2022-10-27 16:00Financial Performance - The company's operating revenue for Q3 2022 was RMB 18,130.58 million, representing a 10.78% increase compared to RMB 16,366 million in the same period last year[2]. - Net profit attributable to shareholders was RMB 2,593.69 million, an increase of 26.96% from RMB 2,042.96 million year-on-year[3]. - The net profit after deducting non-recurring gains and losses was RMB 2,602.47 million, reflecting a 28.19% increase compared to RMB 2,030.22 million in the previous year[3]. - The basic earnings per share for the period was RMB 0.133, up 18.75% from RMB 0.112 in the same quarter last year[3]. - Operating revenue increased by 13.50% year-to-date due to the growth in nuclear power and new energy installed capacity and on-grid electricity volume[8]. - Net profit attributable to shareholders increased by 20.30% year-to-date, primarily driven by the increase in on-grid electricity volume and market electricity prices[8]. - Net profit excluding non-recurring items rose by 21.71% year-to-date, reflecting the overall increase in net profit[8]. - Total operating revenue for the first three quarters of 2022 reached ¥52.70 billion, a 13.0% increase from ¥46.43 billion in the same period of 2021[17]. - Net profit for the first three quarters of 2022 was ¥14.51 billion, representing a 23.4% increase compared to ¥11.77 billion in 2021[18]. - Total profit for the first three quarters of 2022 was ¥17.38 billion, a 24.0% increase from ¥13.98 billion in 2021[18]. Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date was RMB 33,904.93 million, a 21.17% increase from RMB 27,981.44 million in the same period last year[3]. - Cash flow from operating activities for the first three quarters of 2022 was ¥57.75 billion, an increase from ¥49.72 billion in the previous year[20]. - Operating cash inflow totaled CNY 60.32 billion, up from CNY 51.52 billion year-over-year, representing a growth of approximately 17.5%[21]. - The company reported a net cash outflow from operating activities of CNY -150,944,282.75 for the first three quarters of 2022, compared to a net inflow of CNY 42,032,538.36 in the same period of 2021[29]. - Cash and cash equivalents increased by 78.85%, attributed to net inflows from operating and financing activities exceeding net outflows from investing activities[8]. - Cash and cash equivalents at the end of the period were CNY 22.59 billion, up from CNY 15.56 billion, reflecting a strong cash position[22]. Assets and Liabilities - Total assets at the end of the reporting period reached RMB 444,294.20 million, an increase of 8.39% from RMB 409,621.39 million at the end of the previous year[3]. - The company's current assets totaled RMB 76.84 billion, up from RMB 57.81 billion in the previous year, indicating a year-over-year increase of about 32.9%[14]. - Total liabilities reached RMB 295.91 billion, up from RMB 284.34 billion, which is an increase of about 4.5%[15]. - The company's total assets amounted to CNY 81,592,054,229.01, up from CNY 73,163,601,291.78 year-on-year[25]. - The company’s total liabilities decreased to CNY 10,400,807,150.82 from CNY 12,999,219,209.28 year-on-year[25]. Shareholder Information - The company reported a total equity attributable to shareholders of RMB 90,780.69 million, an increase of 18.98% from RMB 76,123.22 million year-on-year[3]. - The total number of ordinary shareholders at the end of the reporting period was 393,783[10]. - The largest shareholder, China National Nuclear Corporation, held 59.37% of the shares[11]. Investment and Expenses - Investment income increased by 79.34% year-to-date, mainly from higher returns on investments in joint ventures and associates[9]. - Research and development expenses for the first three quarters of 2022 amounted to ¥956.24 million, up 20.6% from ¥792.96 million in 2021[17]. - The company’s financial expenses for the first three quarters of 2022 were CNY 175,111,853.21, an increase from CNY 149,691,719.87 in the same period of 2021[26]. Other Financial Metrics - The company recognized a non-recurring gain of RMB 267 million from adjustments related to trial operation sales in the previous year[5]. - Government subsidies recognized during the period amounted to RMB 13.66 million, contributing to the overall financial performance[6]. - The company’s capital reserve increased significantly to CNY 22,084,281,129.72 from CNY 14,999,285,712.83 year-on-year[25]. - The company paid CNY 63.48 billion in debt repayments, up from CNY 43.68 billion, highlighting a focus on debt management[22].